Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

Lantheus Holdings, Inc. Increase (Decrease) in Accounts Receivable

Lantheus Holdings, Inc. (LNTH) reported Increase (Decrease) in Accounts Receivable of -$1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06

  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$3.28M, a 243.18% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $2.23M, a 91.53% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $2.07M.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$12.83M.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $17.89M, a 52.53% decline from fiscal 2024.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $37.69M, a 45.10% decline from fiscal 2023.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $68.64M, a 46.57% decline from fiscal 2022.
  • Lantheus Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $128.46M, a 288.07% increase from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2026-06-30-$3.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.04M
10-Q · filed 2026-08-06
$1.02M
derived: sum of 3 quarters · filed 2026-08-06
-$11.81M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$2.23M
10-Q · filed 2026-05-07
$4.30M
derived: sum of 2 quarters · filed 2026-05-07
-$8.53M
derived: sum of 3 quarters · filed 2026-05-07
-$6.24M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$10.76M
derived: sum of 2 quarters · filed 2026-02-26
-$8.47M
derived: sum of 3 quarters · filed 2026-08-06
$17.89M
10-K · filed 2026-02-26
2025-09-30-$12.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$10.54M
derived: sum of 2 quarters · filed 2026-08-06
$15.82M
10-Q · filed 2025-11-06
$8.62M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$2.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$28.65M
10-Q · filed 2026-08-06
$21.45M
derived: sum of 3 quarters · filed 2026-08-06
-$21.69M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$26.36M
10-Q · filed 2026-05-07
$19.16M
derived: sum of 2 quarters · filed 2026-05-07
-$23.98M
derived: sum of 3 quarters · filed 2026-05-07
$8.61M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$7.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$50.34M
derived: sum of 2 quarters · filed 2026-02-26
-$17.75M
derived: sum of 3 quarters · filed 2026-02-26
$37.69M
10-K · filed 2026-02-26
2024-09-30-$43.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$10.55M
derived: sum of 2 quarters · filed 2025-11-06
$44.89M
10-Q · filed 2025-11-06
$70.48M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$32.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$88.03M
10-Q · filed 2025-08-06
$113.62M
derived: sum of 3 quarters · filed 2026-02-26
$117.59M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$55.44M
10-Q · filed 2025-05-07
$81.03M
derived: sum of 2 quarters · filed 2026-02-26
$85.00M
derived: sum of 3 quarters · filed 2026-02-26
$99.40M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$25.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$29.56M
derived: sum of 2 quarters · filed 2026-02-26
$43.96M
derived: sum of 3 quarters · filed 2026-02-26
$68.64M
10-K · filed 2026-02-26
2023-09-30$3.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$18.36M
derived: sum of 2 quarters · filed 2024-11-06
$43.04M
10-Q · filed 2024-11-06
$59.47M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$14.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$39.08M
10-Q · filed 2024-07-31
$55.51M
derived: sum of 3 quarters · filed 2025-02-26
$66.54M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$24.68M
10-Q · filed 2024-05-02
$41.11M
derived: sum of 2 quarters · filed 2025-02-26
$52.15M
derived: sum of 3 quarters · filed 2025-02-26
$67.99M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$16.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$27.47M
derived: sum of 2 quarters · filed 2025-02-26
$43.30M
derived: sum of 3 quarters · filed 2025-02-26
$128.46M
10-K · filed 2025-02-26
2022-09-30$11.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$26.88M
derived: sum of 2 quarters · filed 2023-11-02
$112.03M
10-Q · filed 2023-11-02
$137.41M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$15.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$100.99M
10-Q · filed 2023-08-03
$126.38M
derived: sum of 3 quarters · filed 2024-02-22
$135.65M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$85.16M
10-Q · filed 2023-05-04
$110.54M
derived: sum of 2 quarters · filed 2024-02-22
$119.81M
derived: sum of 3 quarters · filed 2024-02-22
$115.91M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$25.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$34.65M
derived: sum of 2 quarters · filed 2024-02-22
$30.76M
derived: sum of 3 quarters · filed 2024-02-22
$33.10M
10-K · filed 2024-02-22
2021-09-30$9.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$5.38M
derived: sum of 2 quarters · filed 2022-11-03
$7.72M
10-Q · filed 2022-11-03
$14.48M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30-$3.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$1.55M
10-Q · filed 2022-08-04
$5.21M
derived: sum of 3 quarters · filed 2023-02-23
$8.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$2.35M
10-Q · filed 2022-04-29
$9.11M
derived: sum of 2 quarters · filed 2023-02-23
$11.89M
derived: sum of 3 quarters · filed 2023-02-23
$8.06M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$6.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$9.55M
derived: sum of 2 quarters · filed 2023-02-23
$5.71M
derived: sum of 3 quarters · filed 2023-02-23
$7.46M
10-K · filed 2023-02-23
2020-09-30$2.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$1.05M
derived: sum of 2 quarters · filed 2021-11-04
$703.00K
10-Q · filed 2021-11-04
$3.63M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$3.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
-$2.09M
10-Q · filed 2021-07-28
$835.00K
derived: sum of 3 quarters · filed 2022-02-24
-$4.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$1.75M
10-Q · filed 2021-05-04
$4.67M
derived: sum of 2 quarters · filed 2022-02-24
-$161.00K
derived: sum of 3 quarters · filed 2022-02-24
$554.00K
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$2.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$1.91M
derived: sum of 2 quarters · filed 2022-02-24
-$1.20M
derived: sum of 3 quarters · filed 2022-02-24
-$156.00K
10-K · filed 2022-02-24
2019-09-30-$4.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$4.12M
derived: sum of 2 quarters · filed 2020-11-05
-$3.08M
10-Q · filed 2020-11-05
-$6.30M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$715.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$1.75M
10-Q · filed 2020-07-31
-$1.47M
derived: sum of 3 quarters · filed 2021-02-25
$1.52M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.04M
10-Q · filed 2020-04-30
-$2.18M
derived: sum of 2 quarters · filed 2021-02-25
$802.00K
derived: sum of 3 quarters · filed 2021-02-25
-$2.79M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$3.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$238.00K
derived: sum of 2 quarters · filed 2021-02-25
-$3.83M
derived: sum of 3 quarters · filed 2021-02-25
$3.98M
10-K · filed 2021-02-25
2018-09-30$2.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
-$611.00K
derived: sum of 2 quarters · filed 2019-10-31
$7.21M
10-Q · filed 2019-10-31
$6.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$3.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
$4.22M
10-Q · filed 2019-07-25
$3.02M
derived: sum of 3 quarters · filed 2020-02-25
$1.26M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$7.82M
10-Q · filed 2019-04-30
$6.61M
derived: sum of 2 quarters · filed 2020-02-25
$4.86M
derived: sum of 3 quarters · filed 2020-02-25
$8.09M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$2.96M
derived: sum of 2 quarters · filed 2020-02-25
$272.00K
derived: sum of 3 quarters · filed 2020-02-25
$3.41M
10-K · filed 2020-02-25
2017-09-30-$1.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$1.47M
derived: sum of 2 quarters · filed 2018-10-30
$4.61M
10-Q · filed 2018-10-30
$6.74M
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30$3.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$6.37M
10-Q · filed 2018-08-01
$8.50M
derived: sum of 3 quarters · filed 2019-02-20
$5.42M
derived: sum of 4 quarters · filed 2019-02-20
2017-03-31$3.13M
10-Q · filed 2018-05-02
$5.26M
derived: sum of 2 quarters · filed 2019-02-20
$2.19M
derived: sum of 3 quarters · filed 2019-02-20
$1.56M
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31$2.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
-$950.00K
derived: sum of 2 quarters · filed 2019-02-20
-$1.57M
derived: sum of 3 quarters · filed 2019-02-20
$1.06M
10-K · filed 2019-02-20
2016-09-30-$3.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$3.71M
derived: sum of 2 quarters · filed 2017-11-02
-$1.07M
10-Q · filed 2017-11-02
-$267.00K
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$625.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$2.01M
10-Q · filed 2017-08-01
$2.81M
derived: sum of 3 quarters · filed 2018-02-26
$6.28M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$2.63M
10-Q · filed 2017-05-02
$3.44M
derived: sum of 2 quarters · filed 2018-02-26
$6.91M
derived: sum of 3 quarters · filed 2018-02-26
$5.41M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$804.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$4.27M
derived: sum of 2 quarters · filed 2018-02-26
$2.77M
derived: sum of 3 quarters · filed 2018-02-26
$14.00K
10-K · filed 2018-02-26
2015-09-30$3.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01
$1.97M
derived: sum of 2 quarters · filed 2016-11-01
-$790.00K
10-Q · filed 2016-11-01
$390.00K
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30-$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$4.26M
10-Q · filed 2016-08-04
-$3.08M
derived: sum of 3 quarters · filed 2017-02-23
-$4.43M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31-$2.76M
10-Q · filed 2016-05-03
-$1.58M
derived: sum of 2 quarters · filed 2017-02-23
-$2.93M
derived: sum of 3 quarters · filed 2017-02-23
2014-12-31$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$173.00K
derived: sum of 2 quarters · filed 2017-02-23
$3.56M
10-K · filed 2017-02-23
2014-09-30-$1.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$2.38M
10-Q · filed 2015-11-04
2014-06-30$3.74M
10-Q · filed 2015-08-05
2013-12-31-$2.63M
10-K · filed 2016-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B